Market Overview

Novo Nordisk Posts 35% Rise In Q3 Profit, Lifts 2012 Forecast

Share:
Related NVO
Novo Nordisk Announces Positive Phase 2 Trial Results, Shares Spike Higher
Morning Market Gainers
Orgenesis is Leading the Paradigm Shift in Diabetes Treatments (NVO, ORGS, MNKD) (Small Cap Network)

Novo Nordisk A/S (NYSE: NVO) reported a 35% rise in its third-quarter net profit and lifted its full-year earnings forecast.

Novo Nordisk's quarterly net profit surged to DKK5.67 billion, from DKK4.20 billion, in the year-ago period. However, analysts were expecting a profit of DKK5.27 billion.

Novo Nordisk shares closed at $161.29 yesterday.

Posted-In: profitEarnings News Guidance

 

Related Articles (NVO)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→